TaiMed Biologics (4147) — Free Cash Flow Generation Index

Latest as of December 2025: 0.35x

TaiMed Biologics (4147) has a Free Cash Flow Generation Index of 0.35x as of December 2025. Free cash flow of NT$9.20 Million represents 0% of operating cash flow (NT$25.95 Million). Explore TaiMed Biologics capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.35x

Free Cash Flow / Operating CF

Free Cash Flow

NT$9.20 Million

TWD

Operating Cash Flow

NT$25.95 Million

TWD

Capital Expenditures

NT$16.75 Million

TWD

TaiMed Biologics Free Cash Flow Generation Index (2025–2025)

Historical FCF Generation Index trend for TaiMed Biologics across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of TaiMed Biologics.

Annual Free Cash Flow Generation for TaiMed Biologics (2025–2025)

Year-by-year Free Cash Flow Generation Index for TaiMed Biologics. Check TaiMed Biologics investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (TWD)	Operating CF	Capital Expenditures	YoY Change
2025	0.88x	NT$168.38 Million	NT$191.14 Million	NT$22.77 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).